Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
William Gerwick
University of California, San Diego, Department: Biology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Sirenas Marine Discovery
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. William Gerwick is a Scientific Advisor for Sirenas Marine Discovery (Sirenas) and holds equity in the company valued between (b)(4). The percent of equity interest is unknown. The goal of Sirenas is to find efficient ways to harness and translate chemistry from marine organisms for developing new classes of high-impact therapeutics. The project will develop genetic methods and tools for engineering cyanobacteria to identify, express and engineer natural product biosynthetic pathways for the development of new drugs. Dr. William Gerwick will oversee the chemistry effort for this project.
Development of an efficient cyanobacterial platform for heterologous expression and biosynthetic interrogations of natural products.
Project Narrative Marine cyanobacteria are among the richest organisms on the planet for their biologically active secondary metabolites. These natural products represent diverse drugs and drug leads that can be used for applications to human health such as anticancer agents and antibiotics; however, these natural products are often produced in low amounts by organisms that cannot be genetically manipulated or even cultivated. This project will overcome these obstacles by developing methods and tools for engineering cyanobacteria to identify, express, and engineer natural product biosynthetic pathways for the development of new drugs.
Filed on March 15, 2017.
Tell us what you know about William Gerwick's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.